欧洲 · 通讯社与实时数据 · Reuters Business
India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand
Indian drugmaker Torrent Pharmaceuticals reported a near 10% decline in second-quarter profit on Friday, as higher spending on research and development outpaced robust demand…
在 Reuters Business 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.reuters.com)
